Analyst Joseph Bonner says Microsoft's AI and cloud investments will help the company maintain long-term growth. Argus has a "buy" rating and $526 price target for MSFT stock, which closed at $410 ...
Researchers hope the AI tool will aid in the development of cell-specific gene therapies to treat diseases such as cancer.
It is also a major investor in AI development including AI infrastructure. Argus maintained a Buy rating on Amazon (NASDAQ:AMZN) with a price target of $230, making it the top pick for 2025 in the ...